The decision to include a section of CBD seeds in Dinafem Seeds’ catalogue was the result of a natural evolution. That demand became a great challenge to us. However, as usual, we did not hesitate and we took a step forward with the purpose of meeting the needs and expectations of our customers, by investigating and developing new CBD-rich products. …

Our Research and Development department has devoted several years to this exciting project that has led to the creation of amazing hybrids such as Amnesia CBD, Dinamed CBD, Cheese CBD, Moby Dick CBD, but to name just a few.

Thanks to our customers’ feedback and to the information shared by collaborators all over the world, we have discovered that the market is asking for high-CBD cannabis seeds for recreational use as well as for the treatment of certain pathologies or side effects of serious diseases.

All the cannabis seeds with CBD that Dinafem Seeds has so far created have obtained great results as well as excellent reviews. All of them are part of a new cannabis generation which will make up a range with really valuable therapeutic properties and a moderate effect. We do know our project is complex, but we are fortunate to count with a highly experienced human and technical team that will allow us to succeed in driving this initiative for which we are cooperating with other seed banks and social agents involved in projects related to CBD seeds.

We work hard so that all our seeds with high CBD content offer the preserve the distinctive organoleptic properties that one would expect from Dinafem Seeds. It is one of our aims to provide users of cannabidiol-rich marijuana with the possibility to enjoy not only the therapeutic properties of this kind of cannabis but also the pleasure of tasting it, which is ideally done through a vaporizer.

All our strains are subject to a rigorous testing and quality control process in our laboratories. A seed can only be placed in the CBD seeds section of Dinafem Seeds when a balance has been found between the THC, a psychoactive cannabinoid famous for its appetite-stimulating properties or for its analgesic effect, and the CBD, a non-psychoactive cannabinoid with major therapeutic potential and anti-inflammatory effects. The key is to boost the medical benefits that these substances can offer and reduce their psychoactivity. We are faced with a broad-range phenomenon with a large field ahead waiting to be explored, and we want to be part of it.